We are combining our world-renowned expertise in chemistry and pharmacology to enhance therapies to benefit patients locally, nationally, and globally. The University of Liverpool's new Therapeutics Innovation Frontier will streamline collaboration and enable industry partners to engage with us through open innovation platforms.

Our strategic partnerships have the potential to deliver transformative impact. Building on Liverpool City Region’s outstanding track record for conducting specialised clinical trials, the University is bringing together world-leading clinical academics and hospitals to develop next generation therapeutics.

The platform's overarching aim is to improve drug development and the delivery pathway.

Professor Shampa Das, Professor of Antimicrobial Therapeutics

THE Connect podcast: Therapeutics

Frontier leads Professor Paul O’Neill, Professor Shampa Das and Professor Reecha Sofat discuss the scope of therapeutics research and how it will aid closer collaboration between academia and industry across health and life sciences.
Cancer cells

New Academy of Medical Sciences Fellows

Read about new University of Liverpool Fellows recognised for their contributions to advancing biomedical and health sciences, and translating developments into patient and societal benefits.
Mother walking carrying baby

Case study: HIV transmission

Discover DolPHIN2, a study aiming to reduce the rate of vertical transmission of HIV through research into a new drug.
Woman having a mammogram examination

Case study: cancer testing

We examine whether socioeconomic factors play a part in people getting tested for the breast cancer gene.
Pioneering tools for managing drug-drug interactions in HIV and hepatitis Photograph showing lots of medicine containers on a shelf in a lab

Case study: Managing drug-drug interactions in HIV

Find out how we’re developing innovative prescribing tools to identify and manage risk in HIV and hepatitis.

Collaborate with us

Are you looking for academic expertise to take your ideas to the next level? Get in touch and let us help you connect with our researchers.